DNA methylation (DNAm) is heritable and plays a role in brain development and function through transcriptional regulation. Aberrant DNAm in human brain has been linked to psychiatric disorders, potentially as mediators of common genetic risk variants. In this study, we hypothesize that common risk variants for psychiatric disorders may act through affecting DNAm level in human brain. We first aimed to investigate the heritability pattern of DNAm levels in the human prefrontal cortex. Secondly, through imputation-driven methylome-wide association study (MWAS), we aimed to identify CpG sites whose methylation levels are genetically associated and that show methylation-trait associations in the prefrontal cortex of patients with schizophrenia or bipolar disorder. Our heritability analysis showed that, of ~370,000 CpG sites measured with the Illumina HumanMethylation450 microarray, 17% were heritable (p < 0.05), with a mean heritability of 0.22. Heritable CpG sites were enriched in intergenic regions, CpG shore, and regulatory regions in prefrontal cortex. Our MWAS approach identified known and potentially novel risk genes harboring CpG sites of methylation-trait associations for schizophrenia or bipolar disorder, which were not detectable using three alternative strategies (blood-based methylome reference, transcriptome-wide association study, and two gene-based association tests). Gene set enrichment analysis for genes with methylation-trait association evidence revealed pathways clearly related to neuronal functions, but also highlighted additional biological mechanisms that may underlie psychiatric disorders, such as microRNA-related regulation. In conclusion, our results showed the power of integrating brain methylation data with GWAS for psychiatric risk gene discovery, with potential applications in brain-related disorders or traits. peripheral tissue (blood), which may not correlate with methylation signals in the brain (18, 19).Additionally, due to the challenges of accessing brain tissues, studies that examined brain samples were often limited by small sample size. Finally, it is hard to establish a causal role between DNAm change and disease as it is unclear whether aberrant DNAm causes disease or vice versa.Genome-wide association studies (GWAS) indicate that most common genetic risk variants underlying complex diseases are noncoding and enriched in regulatory genomic regions in cells or tissues related to disease (20), suggesting that risk variants may act through regulation of cell/tissue-specific molecular mechanisms, such as methylation or gene expression. For example, SCZ risk variants from GWAS were enriched at enhancers active in brain, but not in tissues unlikely to be relevant to SCZ (21). Furthermore, statistical genetic approaches like linkage disequilibrium (LD) score regression have shown enrichment of trait heritability in regions with functional annotations that are trait-related and cell-type-specific, including enrichment of heritability for SCZ and BP in functional regions specific to th...